Search
for
Sort by
Research 931–960 of 1000+
- Alopecia Areata Associated with Dupilumab: National Database Study
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- The Genetic Architecture of Alopecia Areata
- Collider bias undermines our understanding of COVID-19 disease risk and severity
- Androgen sensitivity gateway to COVID‐19 disease severity
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Artificial Infestation of Sarcoptes scabiei (Acari: Sarcoptidae) in Rabbits Exhibits Progressive Pathological Changes, Apoptosis, and Keratinization in the Skin
- Antioxidant Constituents of Hops (Humulus lupulus L.) as Functional Raw Materials for Cosmetic Applications
- Green Surface Engineering of Spun-Bonded Nonwovens Using Polyphenol-Rich Berry Extracts for Bioactive and Functional Applications
- Endoscopic assisted facial rejuvenation: a 35 year personal journey
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- The Sinicization of “ojas”, the Formation of “鬼舐/剃頭 Ghost Licking/Shaving Head”, and the Authenticity of the Guanding Sūtra
- Neuroendocrine, Neurotransmitter, and Gut Microbiota Imbalance Contributing to Potential Psychiatric Disorder Prevalence in PCOS
- Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
- Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review
- Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review
- Paradoxical reactions in the era of modern biological therapy of psoriasis — a comprehensive analysis of pathomechanisms and clinical guidelines
- Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features
- Ethanol Enhances Neurosteroidogenesis in Hippocampal Pyramidal Neurons by Paradoxical NMDA Receptor Activation
- The anti-androgen combination, flutamide plus finasteride, paradoxically suppressed LH and androgen concentrations in pregnant spotted hyenas, but not in males
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- The Paradox of p53: What, How, and Why?